Cardiometabolic Adaptations to Concurrent Training: Effect of Effort Configuration on Postmenopausal Women
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age46-65
SponsorUniversidade da Coruña
About this trial
The main objectives of this project are to assess the effects of a 20-week concurrent training program on neuromuscular adaptations, body composition, cardiometabolic health, quality of life, mood state, physical self-perception, and menopause-related symptoms in physically active postmenopausal women, and to compare the adaptations resulting from different combinations of endurance and resistance training programs with varying effort configurations.
Additionally, this project aims to examine the longitudinal interaction and potential interference effects between endurance and resistance training effort configurations throughout the training program and to determine the optimal combination of effort configurations that maximizes health benefits in concurrent training programs for physically active postmenopausal women.
Eligibility criteria
Qualifiers
At least one year since the last menstrual period.
Physically active, defined as engaging in 150-300 minutes of moderate physical activity per week or at least 75 minutes of vigorous activity per week.
Three or fewer traditional cardiovascular risk factors.
Asymptomatic and without cardiovascular (except controlled hypertension), metabolic, or renal diseases.
Disqualifiers
Diagnosis of grade 2 or grade 3 hypertension.
Hypertension managed with more than one medication or with a drug that could interfere with cardiovascular responses to exercise (e.g., beta-blockers).
Current or prior use of hormone replacement therapy.
Hypertensive response to exercise.
Trial design
Treatments tested in this trial
- Concurrent Training Program
Treatment groups
60 Participants
are divided into 6 treatment groups6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Universidade da Coruña
Lead sponsor
Ministerio de Ciencia e Innovación, Spain
Collaborator
Source ClinicalTrials.gov